FDA.reportPublic FDA data

MS 200 MG Extended Release Oral Tablet [MS Contin]

RxCUI
892648
RxNorm name
MS 200 MG Extended Release Oral Tablet [MS Contin]
Display name
MS 200 MG Extended Release Oral Tablet [MS Contin]
Full name
MS 200 MG Extended Release Oral Tablet [MS Contin]
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c354b3bf-86c0-4bb8-8b1f-be2164942698MS Contin 200 MG Extended Release Oral Tablet [PSN] · morphine sulfate 200 MG Extended Release Oral Tablet [MS Contin] [SBD] · MS 200 MG Extended Release Oral Tablet [MS Contin] [SY] · MS Contin 200 MG Extended Release Oral Tablet [SY]416These highlights do not include all the information needed to use MS CONTIN ® safely and effectively. See full prescribing information for MS CONTIN. MS CONTIN ® (morphine sulfate extended-release tablets), for oral use CII Initial U.S. Approval: 194120260504